Biofrontera Inc. has amended its incorporational certificate to initiate a 1-for-20 reverse stock split and reduce the number of its authorized common shares from 300,000,000 to 15,000,000. This will be effective from July 3, 2023, and the post-split common stock will begin trading from July 5, 2023.